# Forensic Dossier: Study Forensics: APJ agonist as pharmacological exercise mimetic

**Run ID:** `full27_study-forensics-030_Claude_Sonnet_c6dad3`  
**Task:** study-forensics-030 | study_forensics | medium | study_forensics  
**Timestamp:** 2026-04-08T18:02:13.907126+00:00  
**Task Family:** mechanism_vs_evidence  
**Trap Type:** preclinical_to_therapeutic_leap  
**Ambiguity:** low  

## Executive Summary

**Agents tested:** Claude Sonnet
**Winner:** Claude Sonnet — **65.7/100** (margin: 0.0)
**Failure modes:** decorative_self_check, decorative_uncertainty, unsupported_conclusion, unsupported_intermediate_step
**Forensic flags:** 3
**Consistency findings:** 5
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Sonnet | 30.0/30 | 0.0/8 | 4.8/8 | 4.8/6 | 3.6/6 | 4.5/6 | 0.0/8 | 8.0/8 | 0.0/10 | 10.0/10 | **65.7/100** |

## Study Forensics Audit

### Claude Sonnet

**Classification:** `mechanism_vs_evidence` [+] (gold: `mechanism_vs_evidence`)
**Finding Recall:** 100%
**Matched Findings:** mechanism_not_demonstrated, conclusion_exceeds_results
**Extra Findings:** cautious_scope_control, correlation_as_causation

## Reasoning Integrity Audit

### Claude Sonnet
**Classification:** Correct but brittle reasoning
**Load-bearing steps:** 0 / 6

## Mechanism Analysis

### Claude Sonnet
| Aspect | Status |
|--------|--------|
| Concept named | :x: none |
| Mechanism described | :x: (0 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** concept not named, mechanism not described, mechanism not grounded to case data

## Grounding Audit

### Claude Sonnet
Conclusion claims: 1
- Direct support: 0
- Indirect support: 0
- Unsupported: 1
- Contradicted: 0

**Unsupported claims:**
- "mechanism_vs_evidence"


## Forensic Flags

### Claude Sonnet

- **[MODERATE]** `weak_mechanism`: Correct answer but weak mechanism explanation — answer may not generalize
  - `final_answer`: "mechanism_vs_evidence"
- **[MAJOR]** `unsupported_leap`: Correct answer with weak support chain — final answer may be an unsupported leap
- **[MODERATE]** `unsupported_conclusion_claims`: 1/1 conclusion claims lack step support
  - `final_answer`: "mechanism_vs_evidence"


## Evidence Map

### Claude Sonnet

**Correctness:** 30.0/30
  - (+) `final_answer`: "mechanism_vs_evidence"
    _Agent's answer for correctness check_
  - Note: Exact match

**Support Strength:** 0.0/8
  - (-) `final_answer`: "mechanism_vs_evidence"
    _Conclusion not supported by steps_
  - Note: Support classification: 0 load-bearing, 0 supporting, 0 mentioned / 6
  - Note: Reasoning graph: conclusion not well grounded

**Structural Reasoning:** 4.8/8
  - (+) `steps[1]`: "Identified conclusion tier as human therapeutic (company claims about pharmacological exercise mimetic for humans)"
    _Most informative reasoning step_
  - Note: 6 reasoning steps
  - Note: Low step utility: 0/6 steps contribute

**Assumption Discipline:** 4.8/6
  - (+) `assumptions[1]`: "The company is making claims about human therapeutic potential"
    _Most substantive assumption_
  - Note: 3/3 substantive assumptions

**Uncertainty Handling:** 3.6/6
  - (+) `uncertainties[1]`: "Whether any preliminary human safety data exists but wasn't mentioned"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.9"
    _Stated confidence level_
  - (-) `uncertainties[0]`: "Exact wording of company's claims - summary may paraphrase"
    _Listed but never addressed in reasoning_
  - Note: 2 uncertainties (2 substantive)
  - Note: 1 decorative uncertainty(ies)

**Alternative Hypothesis Quality:** 4.5/6
  - (+) `alternative_hypotheses[1]`: "Could be overclaim if language was more promotional about guaranteed human benefits"
    _Most substantive alternative hypothesis_
  - Note: 2 alternative hypotheses considered
  - Note: 2/2 genuinely diverse alternatives

**Self Monitoring Quality:** 0.0/8
  - (+) `self_check[1]`: "Confirmed this is not correlation_vs_causation - deals with mechanism claims"
    _Most substantive self-verification step_
  - (-) `self_check[0]`: "Confirmed this is not overclaim - language is cautious, not promotional"
    _Fluff self-check_
  - Note: 4 self-check items
  - Note: Self-check quality: 0 deep, 0 arithmetic, 4 fluff

**Mechanism Quality:** 0.0/10
  - Note: Neither names concept nor explains mechanism

**Communication Efficiency:** 10.0/10
  - Note: Signal density: 0.76, 216 words

**Insight Depth:** 8.0/8
  - Note: Key insights: 2 full / 2


## Failure Analysis

### Claude Sonnet

**MODERATE:**
- **Unsupported Conclusion** `[MEDIUM CONFIDENCE]`: Final answer lacks load-bearing or supporting step grounding
  - `final_answer`: "mechanism_vs_evidence"
  - _Impacts: support_strength_
- **Unsupported Intermediate Step** `[MEDIUM CONFIDENCE]`: No reasoning step is load-bearing — final answer lacks traceable derivation
  - `final_answer`: "mechanism_vs_evidence"
  - _Impacts: support_strength, structural_reasoning_

**MINOR:**
- **Decorative Self Check** `[HEURISTIC]`: All 4 self-checks appear to be fluff — no substantive verification
  - `self_check[0]`: "Confirmed this is not overclaim - language is cautious, not promotional"
  - _Impacts: self_monitoring_quality_

**STYLISTIC:**
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'Exact wording of company's claims - summary may paraphrase...' is listed but not addressed
  - `uncertainties[0]`: "Exact wording of company's claims - summary may paraphrase"
  - _Impacts: uncertainty_handling_


## Consistency & Grounding Audit

### Claude Sonnet

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (0/8 content words)
  - `key_claims[0]`: "Animal study results are being used to imply human therapeutic potential"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (0/11 content words)
  - `key_claims[1]`: "The apelin pathway concept as 'exercise mimetic' bridges from mouse physiology to human application"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (0/8 content words)
  - `key_claims[2]`: "Company is positioning this for human translation despite only having animal data"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 1 is stated without rejection reasoning
  - `alternative_hypotheses[0]`: "Could be solid if claims were limited to mouse model results"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 2 is stated without rejection reasoning
  - `alternative_hypotheses[1]`: "Could be overclaim if language was more promotional about guaranteed human benefits"


## Agent Profiles

### Claude Sonnet (claude-sonnet-4-20250514)
**Parse OK:** True | **Latency:** 11311ms

**Final Answer:** mechanism_vs_evidence

**Confidence:** 0.9

**Assumptions:**
- The study was conducted in mouse models
- The company is making claims about human therapeutic potential
- No human data is presented in this summary

**Reasoning Steps:**
1. Identified evidence tier as animal studies (obese/diabetic mice, heart-failure model)
2. Identified conclusion tier as human therapeutic (company claims about pharmacological exercise mimetic for humans)
3. Found clear bridge step from mouse studies to human therapeutic implications
4. Assessed whether bridge is supported - no human data provided
5. Noted cautious language ('could serve', 'preparing to translate') but this doesn't resolve the tier mismatch
6. Applied key rule: hedging acknowledges gap but doesn't close it

**Key Claims:**
- Animal study results are being used to imply human therapeutic potential
- The apelin pathway concept as 'exercise mimetic' bridges from mouse physiology to human application
- Company is positioning this for human translation despite only having animal data

**Alternative Hypotheses:**
- Could be solid if claims were limited to mouse model results
- Could be overclaim if language was more promotional about guaranteed human benefits

**Uncertainties:**
- Exact wording of company's claims - summary may paraphrase
- Whether any preliminary human safety data exists but wasn't mentioned

**Self-Verification:**
- Confirmed this is not overclaim - language is cautious, not promotional
- Confirmed this is not correlation_vs_causation - deals with mechanism claims
- Verified the tier mismatch exists - mouse studies implying human benefit
- Did not overflag - the mouse results themselves appear solid

**Dimension Scores:**
- Correctness: 30.0/30 `##########`
- Support Strength: 0.0/8 `..........`
- Structural Reasoning: 4.8/8 `######....`
- Assumption Discipline: 4.8/6 `########..`
- Uncertainty Handling: 3.6/6 `######....`
- Alternative Hypothesis Quality: 4.5/6 `#######...`
- Self Monitoring Quality: 0.0/8 `..........`
- Insight Depth: 8.0/8 `##########`
- Mechanism Quality: 0.0/10 `..........`
- Communication Efficiency: 10.0/10 `##########`


## Final Verdict

**Solo run: Claude Sonnet** scored **65.7/100**.

**Best per dimension:**
- Correctness: Claude Sonnet (30.0/30)
- Support Strength: Claude Sonnet (0.0/8)
- Structural Reasoning: Claude Sonnet (4.8/8)
- Assumption Discipline: Claude Sonnet (4.8/6)
- Uncertainty Handling: Claude Sonnet (3.6/6)
- Alternative Hypothesis Quality: Claude Sonnet (4.5/6)
- Self Monitoring Quality: Claude Sonnet (0.0/8)
- Insight Depth: Claude Sonnet (8.0/8)
- Mechanism Quality: Claude Sonnet (0.0/10)
- Communication Efficiency: Claude Sonnet (10.0/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Sonnet | 11.3s | 65.7/100 | 5.8 |

Failure modes observed: decorative_self_check, decorative_uncertainty, unsupported_conclusion, unsupported_intermediate_step.
